A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/232 (2006.01) A61K 31/7056 (2006.01) A61K 38/21 (2006.01) A61P 1/16 (2006.01) A61P 7/06 (2006.01) A61P 31/12 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2516333
There is provided a drug for reducing side effects, anemia in particular, in combination therapy of chronic hepatitis C with ribavirin and interferon, which contains as the active ingredient at least one member selected from the group consisting of eicosapentaenoic acid (EPA) and pharmaceutically acceptable salts and esters thereof.
L'invention concerne un médicament pour atténuer les effets secondaires (et notamment l'anémie) dans la thérapie combinée d'interféron ribaverine dirigée contre l'hépatite C, qui contient en tant qu'ingrédient actif au moins un élément sélectionné dans le groupe constitué d'acide eicosapenténoïque (EPA) et de leurs sels et esters pharmaceutiquement acceptables.
Ide Tatsuya
Okamura Takashi
Sata Michio
Mochida Pharmaceutical Co. Ltd.
Smart & Biggar
LandOfFree
Drug for reducing side effects in ribavirin / interferon... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug for reducing side effects in ribavirin / interferon..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug for reducing side effects in ribavirin / interferon... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1704283